33 clinical trials matched your search for Leukemia. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Leukemia Study of Bendamustine/Rituximab Induction Followed by Venetoclax and Rituximab Consolidation for Treatment of Chronic Lymphocytic Leukemia Nicole Lamanna, MD
Leukemia Study of Nivolumab in Combination with 5-Azacytidine in Acute Myeloid Leukemia (AML) - Children and Adults Age 1 to 30 Nobuko Hijiya, MD
Leukemia A Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy Amer Assal, MD
Leukemia Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS) (ENHANCE) Joseph Jurcic, MD
Leukemia Study of Panzyga in Primary Infection Prophylaxis (Prevention) in Patients with Chronic Lymphocytic Leukemia (PRO-SID) Nicole Lamanna, MD
Leukemia A Study of GFH009 in Patients With Hematologic Malignancies Andrew Lipsky, MD
Leukemia Study of BGB-11417 in Patients with Leukemia Nicole Lamanna, MD
Leukemia Study of CGT9486 in Patients with Advanced Systemic Mastocytosis (AdvSM) Mark Heaney, MD, PhD
Leukemia Study for Patients with Chronic Lymphocytic Leukemia (CLL) who are Currently Receiving Treatment with Venetoclax Nicole Lamanna, MD
Leukemia Study of TSC 100 & TSC 101 in Patients with Leukemia Undergoing Haploidentical Allogeneic Blood Stem Cell Transplantation (HCT) Ran Reshef, MD
Leukemia Study of Fedratinib in Combination with Chemotherapy in Patients with Myeloproliferative Neoplasm (MPN) in Accelerated and Blast Phase Joseph Jurcic, MD
Leukemia Study of Pirtobrutinib (LOXO-305) Alone or in Combination With Chemotherapy in Patients with Chronic Lymphocytic Leukemia (CLL) Nicole Lamanna, MD
Leukemia Study of TL-895 Alone or in Combination with KRT-232 for Patients with Myelofibrosis (MF) Mark Heaney, MD, PhD
Leukemia Study of Venetoclax and Azacitidine After Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia (AML) Amer Assal, MD
Leukemia Study of Polatuzumab Vedotin in Combination with Chemotherapy in Subjectswith Richter's Transformation Andrew Lipsky, MD
Leukemia Study of BLU-263 in Patients with Indolent Systemic Mastocytosis (ISM) or Monoclonal Mast Cell Activation Syndrome (mMCAS) Joseph Jurcic, MD
Leukemia Study of Drug - DSP-5336 in Patients with Leukemia Joseph Jurcic, MD
Leukemia Study of Magrolimab in Combination with Chemotherapy in Patients with Acute Myeloid Leukemia (AML) Joseph Jurcic, MD
Leukemia Study of STK-009 in Combination with SYNCAR-001 in Patients with Lymphoma or Leukemia Ran Reshef, MD
Cancer Study of Drug in Patients with Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Nicole Lamanna, MD
Cancer A Study of MS-553 in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Nicole Lamanna, MD
Cancer LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkins Lymphoma Nicole Lamanna, MD
Childhood Leukemia Study of Nivolumab in Combination with 5-Azacytidine in Acute Myeloid Leukemia (AML) - Children and Adults Age 1 to 30 Nobuko Hijiya, MD
Cancer Safety Study of PBCAR0191 in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma and r/r B-cell Acute Lymphoblastic Leukemia Ran Reshef, MD
Cancer Smartphone App for Cancer Medication Adherence Melissa Accordino, MD
Lymphoma Dose-escalation Safety Study of PBCAR19B in Participants With CD19-expressing Malignancies (Non Hodgkin Lymphoma) Ran Reshef, MD
Cancer Study of New Oral Anti-Cancer Drug (OACD) Dawn Hershman, MD
Cancer Study of Financial Navigator Addressing Cancer-Related Financial Hardship in Cancer Patients and Their Spouses Dawn Hershman, MD
Lymphoma Study of LOXO-305 in Patients with Mantle Cell Lymphoma (MCL) Andrew Lipsky, MD
Cancer Study of CS5001 in Patients with Advanced Solid Tumors Richard Carvajal, MD
Cancer ACCESS: Study of Donor Blood Stem Cell Transplant in Patients with Multiple Myeloma, Leukemia, or Lymphoma Ran Reshef, MD
Lymphoma Study of Lenalidomide in Combination with Chemotherapy in Patients with HTLV-Associated Adult T-Cell Leukemia-Lymphoma (ATLL) Jennifer Amengual, MD
Lymphoma Study of STK-009 in Combination with SYNCAR-001 in Patients with Lymphoma or Leukemia Ran Reshef, MD